{"gene":"KLF1","run_date":"2026-06-10T02:59:49","timeline":{"discoveries":[{"year":1995,"finding":"EKLF/KLF1 knockout mice die of anemia during fetal liver erythropoiesis with specific deficit in beta-globin gene expression, establishing that EKLF is required for definitive erythropoiesis and beta-globin activation but is dispensable for yolk sac erythropoiesis and erythroid commitment.","method":"Gene targeting (knockout mouse), hematological and molecular phenotyping","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — independently replicated in two simultaneous knockout studies (PMID:7753195 and PMID:7753194), clean loss-of-function with defined molecular phenotype","pmids":["7753195","7753194"],"is_preprint":false},{"year":1994,"finding":"EKLF binds the CACCC element in the beta-globin promoter via its zinc finger domain; beta-thalassemia point mutations in the CAC site reduce EKLF binding affinity 40–100-fold and abolish EKLF-dependent transactivation, demonstrating that EKLF binding to CACCC is essential for beta-globin transcription.","method":"In vivo reporter transactivation assays, in vitro DNA binding affinity measurements, molecular modeling based on Zif268/DNA co-crystal structure","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro binding assays combined with in vivo transactivation, replicated across multiple mutants, mechanistic mutagenesis data","pmids":["8288615"],"is_preprint":false},{"year":1995,"finding":"EKLF physically interacts with the erythroid transcription factor GATA-1 through their respective DNA-binding domains; GATA-1 and EKLF synergize to activate transcription, providing a mechanism for erythroid-specific gene regulation.","method":"Co-immunoprecipitation, in vitro binding assays, co-transfection transcriptional synergy assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal physical interaction demonstrated in vitro and in vivo with functional synergy assays; replicated in multiple experimental systems within the same study","pmids":["7739528"],"is_preprint":false},{"year":1994,"finding":"GATA-1 directly activates the EKLF gene promoter through a GATA motif at position -60; GATA-1 binding sites and CP1 sites are both required for full EKLF promoter activity, placing EKLF downstream of GATA-1 in the erythroid regulatory hierarchy.","method":"Promoter deletion/mutation analysis, co-transfection assays, DNA binding assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional promoter dissection combined with co-transfection rescue experiments; replicated and extended in later studies (PMID:8603943, PMID:10688820)","pmids":["8195185"],"is_preprint":false},{"year":1998,"finding":"EKLF is acetylated in vivo and interacts with histone acetyltransferases CBP, p300, and P/CAF; CBP and p300 (but not P/CAF) acetylate EKLF within its transactivation domain and enhance EKLF-dependent beta-globin transcription in erythroid cells.","method":"In vivo co-immunoprecipitation, in vitro acetylation assay, co-transfection transcriptional activation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro enzymatic acetylation assay combined with in vivo co-IP and functional transcription assays; single lab but multiple orthogonal methods","pmids":["9707565"],"is_preprint":false},{"year":1998,"finding":"EKLF requires a SWI/SNF-related chromatin remodeling complex (E-RC1, containing BRG1, BAF170, BAF155, INI1, and BAF57) to remodel chromatin at the beta-globin promoter and activate transcription in vitro; this interaction is transcription-factor selective.","method":"In vitro chromatin-assembled transcription assay, biochemical purification of E-RC1 complex, functional reconstitution","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution on chromatin templates in vitro with purified complex, multiple subunit identification; single lab but rigorous biochemistry","pmids":["9778250"],"is_preprint":false},{"year":1998,"finding":"EKLF is phosphorylated at serine and threonine residues within its transactivation region; casein kinase II (CKIIα) interacts with EKLF and phosphorylates Thr-41 within the EKLF interaction domain, and mutation of this CKII site abolishes EKLF transactivation activity.","method":"In vivo phosphorylation analysis, in vitro kinase assay, site-directed mutagenesis, co-transfection transcriptional assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay plus mutagenesis plus in vivo functional assay, single lab, multiple orthogonal methods","pmids":["9722526"],"is_preprint":false},{"year":1996,"finding":"EKLF's proline-rich transactivation domain contains discrete stimulatory and inhibitory subdomains; the inhibitory domain suppresses DNA binding in cis, while a 40 amino acid minimal transactivation domain mediates trans-interaction with a positive-acting cellular factor, and phosphorylation/conformation of this core is critical for these interactions.","method":"Deletion/mutagenesis co-transfection assays, in vitro DNA binding competition assays, in vivo competition assays","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional mutagenesis plus in vitro and in vivo binding/competition assays; single lab, multiple methods","pmids":["8918466"],"is_preprint":false},{"year":1998,"finding":"The mouse EKLF promoter contains a GATA-E box-GATA composite element in which GATA-1 binds both GATA sites and another erythroid factor binds the central E box; all three sites act as a unit (not additively) to drive erythroid-specific EKLF expression in transgenic mice.","method":"Transgenic mouse reporter assays, in vitro DNA binding/gel-shift assays, promoter mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic in vivo validation combined with in vitro binding assays; confirmed in follow-up transgenic study (PMID:10688820)","pmids":["9603943","10688820"],"is_preprint":false},{"year":1998,"finding":"EKLF activates the beta-globin locus control region hypersensitive site 5'HS3 in vivo, as demonstrated by matching point mutations in 5'HS3 CACCC motifs with amino acid substitutions in EKLF zinc fingers that alter DNA-binding specificity.","method":"Altered DNA-binding specificity approach (matched mutations in DNA site and zinc finger), transgenic mouse assay","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — elegant genetic specificity experiment in vivo using matched mutations; single lab but rigorous in vivo validation","pmids":["9744863"],"is_preprint":false},{"year":2004,"finding":"EKLF functions as a stage-specific transcriptional repressor in addition to an activator; it interacts with Sin3A and HDAC1 corepressors via its zinc finger domain, and a key lysine residue serves as both a CBP acetylation substrate and a Sin3A interaction site, linking acetylation status to coactivator vs. corepressor choice.","method":"Co-immunoprecipitation, point mutagenesis, in vivo transcriptional repression assays, stage-specific erythroid cell assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP plus mutagenesis plus functional transcription assays; single lab but multiple orthogonal methods","pmids":["15542849"],"is_preprint":false},{"year":2007,"finding":"EKLF is post-translationally modified by sumoylation at a single site near its amino terminus; PIAS1 is the SUMO E3 ligase for this modification. Sumoylation is required for EKLF's repressive (not activating) function through a SUMO-dependent interaction with the Mi-2β component of the NuRD repression complex, and is important for inhibiting megakaryocyte differentiation.","method":"In vivo sumoylation assay, site-directed mutagenesis, co-immunoprecipitation, gain/loss-of-function transcriptional and lineage differentiation assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo modification plus co-IP of NuRD complex plus mutagenesis plus lineage functional assay; single lab, multiple orthogonal methods","pmids":["17938210"],"is_preprint":false},{"year":2003,"finding":"FLI-1 represses EKLF-dependent transcription by interacting with EKLF (via FLI-1 N- and C-terminal domains) and recruiting the repressive FLI-1 ETS domain to erythroid promoters; reciprocally, EKLF represses the FLI-1-dependent megakaryocytic GPIX promoter, establishing functional cross-antagonism that controls erythroid vs. megakaryocytic lineage choice.","method":"Co-immunoprecipitation, reporter gene transcription assays, Gal4-fusion domain analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — physical interaction plus reciprocal functional repression assays; single lab, multiple orthogonal methods","pmids":["12556498"],"is_preprint":false},{"year":2007,"finding":"EKLF plays a directive role in megakaryocyte-erythroid progenitor lineage commitment: EKLF inhibits megakaryocyte formation while stimulating erythroid differentiation, at least partly by repressing Fli-1 mRNA levels, and is uniquely down-regulated in megakaryocytes after MEP formation.","method":"Gain- and loss-of-function studies in hematopoietic progenitors, expression profiling, molecular analyses of Fli-1 expression","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — both gain- and loss-of-function with quantitative lineage output measurements and defined molecular mechanism (Fli-1 repression); single lab, multiple methods","pmids":["17715392"],"is_preprint":false},{"year":2008,"finding":"EKLF is required for cell cycle progression in erythroid progenitors; loss of EKLF leads to reduced E2f2 (and E2f4) expression, G1-to-S phase delay, and failure of terminal differentiation. EKLF directly occupies the E2f2 proximal promoter in vivo and its binding correlates with DNase I sensitivity.","method":"ChIP assay, transcriptional profiling, cell cycle analysis, EKLF-null mouse analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-confirmed direct occupancy plus cell cycle phenotype in null mouse; single lab, multiple methods","pmids":["18852285"],"is_preprint":false},{"year":2009,"finding":"EKLF directly regulates E2f2 via novel intronic enhancers containing conserved CACC/GATA/E-box elements that are occupied by EKLF in vivo; genetic depletion of Rb in EKLF(-/-) fetal liver partially rescues the cell cycle defect, establishing epistatic linkage between EKLF, E2f2, and cell cycle entry.","method":"ChIP assay, reporter gene assays, genetic epistasis (Rb knockout rescue), cell cycle analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP-confirmed direct binding plus epistasis rescue plus functional reporter assays; replicated in related study (PMID:18852285)","pmids":["19457859"],"is_preprint":false},{"year":2010,"finding":"KLF1 directly activates BCL11A expression in erythroid cells; KLF1 knockdown reduces BCL11A levels and increases gamma-globin/beta-globin expression ratios, establishing that KLF1 controls globin switching by directly activating beta-globin AND indirectly repressing gamma-globin via BCL11A.","method":"shRNA knockdown in human and mouse adult erythroid progenitors, gene expression analysis","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function with defined downstream mechanism (BCL11A), replicated in both human and mouse systems","pmids":["20676097"],"is_preprint":false},{"year":2008,"finding":"KLF1 activates Klf8 gene expression through CACCC sites in both Klf8 promoters; KLF3 competes with KLF1 at these sites to repress Klf8; in Klf3 knockout tissue, KLF1 gains access and activates Klf8 promoters, revealing a direct competitive network between activating (KLF1) and repressing (KLF3) Krüppel-like factors.","method":"Chromatin immunoprecipitation (ChIP), reporter gene assays, Klf3 knockout mouse analysis, promoter competition analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP confirming in vivo binding plus genetic rescue (KO mouse) plus reporter assays; single lab, multiple orthogonal methods","pmids":["18687676"],"is_preprint":false},{"year":2008,"finding":"EKLF acetylation at lysine 288 is essential for recruitment of CBP to the beta-globin locus, histone H3 modification, chromatin opening (DNase I sensitivity), and beta-globin transcription. EKLF's zinc finger domain associates specifically with the histone H3 amino terminus, and H3.3 (not H3.1) is enriched at the beta-globin promoter in an EKLF-dependent manner.","method":"Retroviral EKLF rescue of EKLF-null erythroid line, ChIP, DNase I sensitivity assay, site-directed mutagenesis of K288","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis of acetylation site plus ChIP-based chromatin assays plus functional transcription rescue; single lab, multiple orthogonal methods","pmids":["18710946"],"is_preprint":false},{"year":2002,"finding":"BMP4 signaling through the BMP/Smad pathway is necessary and sufficient to induce EKLF (and GATA1) expression during embryoid body differentiation; dominant-negative BMP receptor or inhibitory Smad6 prevents EKLF induction even in serum, establishing the BMP/Smad pathway as upstream of EKLF expression onset.","method":"Serum-free embryoid body differentiation, BMP4 treatment, dominant-negative receptor/Smad6 expression in ES cells","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function of pathway components with defined molecular readout (EKLF expression); single lab, multiple orthogonal approaches","pmids":["11807044"],"is_preprint":false},{"year":2008,"finding":"Gata2 and Smad5 cooperate to induce Eklf expression in hematopoietic progenitors prior to erythroid commitment; upon erythroid commitment, regulation switches to Gata1-controlled Eklf transcription.","method":"Transgenic reporter assays in differentiating ES cells and fetal liver, phylogenetic footprinting, in vivo ChIP-like binding studies, loss-of-function in embryoid bodies","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo binding studies plus transgenic reporter assays plus loss-of-function; single lab, multiple orthogonal methods","pmids":["18448565"],"is_preprint":false},{"year":2010,"finding":"KLF1 has at least 945 genomic binding sites in E14.5 fetal liver erythroid cells; it occupies promoters of erythroid genes including Hbb-b1 and acts primarily as a transcriptional activator coordinating nearly all aspects of terminal erythroid differentiation including globin production, heme biosynthesis, cell cycle, and red cell membrane/cytoskeleton genes.","method":"KLF1 ChIP-seq in primary mouse erythroid cells","journal":"Genome research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP-seq with direct in vivo occupancy data; large-scale replicated dataset in primary cells","pmids":["20508144"],"is_preprint":false},{"year":2010,"finding":"EKLF directly activates p21(WAF1/CIP1) expression independently of p53 through binding to CACCC motifs in the proximal p21 promoter and a novel conserved intronic region downstream of the TATA box, linking EKLF to cell cycle exit during erythroid maturation.","method":"ChIP assay, promoter-reporter assays with mutational analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-confirmed direct binding at two sites plus reporter assays with mutagenesis; single lab, multiple orthogonal methods","pmids":["20368355"],"is_preprint":false},{"year":2011,"finding":"EKLF's minimal transactivation domain (TAD) contains two functional subdomains (TAD1 and TAD2); TAD2 binds the PH domain of the Tfb1/p62 subunit of TFIIH and four domains of CBP/p300. NMR structure of EKLFTAD2/Tfb1PH complex shows TAD2 binds in an extended conformation (distinct from p53TAD2 alpha-helical binding).","method":"NMR structure determination, in vitro binding assays, sequence/functional domain analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure plus in vitro binding assays; single lab but structural validation with functional data","pmids":["21670263"],"is_preprint":false},{"year":2006,"finding":"EKLF/KLF1 protein is ubiquitinated in vivo and degraded by the 26S proteasome; EKLF half-life is less than 3 hours in MEL cells and 6–9 hours in fetal liver cells; ubiquitination does not require a specific internal lysine, and PEST sequences within the N-terminus contribute to protein destabilization.","method":"Proteasome inhibitor treatment, in vivo ubiquitination assay, pulse-chase protein stability assay, PEST sequence mutagenesis","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo ubiquitination demonstrated plus pharmacological and genetic stability analysis; single lab, multiple methods","pmids":["16579989"],"is_preprint":false},{"year":2008,"finding":"A substantial proportion of endogenous EKLF resides in the cytoplasm at steady state in erythroid cells, not solely in the nucleus; EKLF can shuttle out of the nucleus (demonstrated by heterokaryon assay) with rapid nuclear re-entry; nuclear vs. cytoplasmic EKLF shows subtle biochemical and functional differences.","method":"Subcellular fractionation, heterokaryon shuttle assay, CRM1 inhibition assay","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct fractionation and heterokaryon assay; single lab, functional consequence of cytoplasmic pool not fully established","pmids":["18329016"],"is_preprint":false},{"year":2016,"finding":"EKLF/KLF1 directly regulates p18 and p27 CDK inhibitor expression to control cell cycle exit; loss of EKLF leads to a block at the orthochromatic erythroblast stage with failure of enucleation; reintroduction of either p18 or p27 rescues both cell cycle and enucleation deficits, establishing that EKLF-controlled cell cycle exit is required for enucleation.","method":"Imaging flow cytometry, ex vivo terminal erythroid differentiation culture, epistatic rescue experiments with p18/p27 reintroduction","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — epistatic rescue (p18/p27 reintroduction) plus direct imaging of enucleation; single lab, multiple orthogonal methods","pmids":["27480112"],"is_preprint":false},{"year":2010,"finding":"EKLF is required for proper expression of erythrocyte cytoskeletal protein dematin (band 4.9); EKLF occupies conserved CACC motifs in the dematin gene in vivo and activates transcription through these elements; EKLF also regulates alpha-hemoglobin stabilizing protein (AHSP), cytoskeletal proteins, heme synthesis enzymes, and blood group antigens.","method":"ChIP assay, promoter reporter assay, expression profiling of EKLF-null fetal liver and EKLF-ER inducible cell lines","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-confirmed direct occupancy plus promoter reporter assays plus two complementary expression profiling systems; single lab","pmids":["16380451"],"is_preprint":false},{"year":2011,"finding":"KLF1 directly binds and activates the Dnase2a promoter in the central macrophage of erythroblastic islands; Dnase2a is severely downregulated in Klf1 KO fetal liver; KLF1 is expressed in erythroblastic island macrophages and exerts a non-cell-autonomous role in erythropoiesis by enabling degradation of extruded erythroid nuclei.","method":"ChIP assay (KLF1 occupancy at Dnase2a promoter), KO mouse analysis, expression analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-confirmed direct binding plus genetic KO phenotype; single lab, multiple methods","pmids":["21807894"],"is_preprint":false},{"year":2014,"finding":"EKLF/KLF1 is expressed in erythroblastic island macrophages (derived from erythro-myeloid progenitors) and plays an extrinsic role in erythroid maturation by regulating genes important for island integrity within macrophage cells, in addition to its intrinsic role in erythroid progenitors.","method":"Embryoid body single-progenitor island formation assay, genetic lineage marking, expression analysis in EKLF-expressing macrophages vs. EKLF-null cells","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic lineage demonstration and expression analysis; single lab, island formation assay","pmids":["24866116"],"is_preprint":false},{"year":2009,"finding":"EKLF is recruited to the gamma-globin promoter in primary human erythroid progenitors upon SCFA derivative treatment, functioning as a co-activator for gamma-globin induction; EKLF knockdown prevents SCFA-induced gamma-globin expression; BRG1 is co-recruited to the gamma-globin promoter in an EKLF-dependent manner.","method":"ChIP assay (endogenous promoter), siRNA knockdown, gamma-globin reporter assay","journal":"European journal of haematology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-confirmed recruitment plus functional KD assay; single lab, two orthogonal methods","pmids":["19220418"],"is_preprint":false},{"year":2012,"finding":"KLF1 directly drives dematin and a broad transcriptome of erythroid genes through a cis-regulatory module co-occupied by KLF1, GATA1, TAL1, and EP300; KLF1 is required for expression of novel lncRNAs and directs apoptotic gene expression during terminal erythroid maturation; KLF1 also drives erythroid-specific promoters of ubiquitous genes.","method":"mRNA-seq comparison of Klf1(+/+) vs. Klf1(-/-) erythroid tissue, integration with prior KLF1 ChIP-seq data","journal":"Genome research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide mRNA-seq integrated with ChIP-seq occupancy data in primary cells; large-scale dataset with strong genomic support","pmids":["22835905"],"is_preprint":false},{"year":2012,"finding":"c-Myb directly binds the KLF1 promoter and transactivates KLF1 expression; ChIP and luciferase reporter assays demonstrate this direct regulation; KLF1 overexpression can partially rescue the erythroid defect and megakaryocyte bias caused by c-Myb silencing.","method":"ChIP assay, luciferase reporter assay, retroviral overexpression rescue experiments","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-confirmed direct binding plus reporter assay plus functional rescue; single lab, multiple orthogonal methods","pmids":["20686118"],"is_preprint":false},{"year":2014,"finding":"KLF1 stabilizes GATA-1 and TAL1 occupancy at the beta-globin locus and other erythroid genes; KLF1 knockdown reduces GATA-1 and TAL1 chromatin binding without affecting their protein levels, and abolishes histone acetylation and chromatin looping at target loci.","method":"KLF1 stable knockdown in K562 cells, ChIP assay for multiple factors and histone marks","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP for multiple factors in KLF1 knockdown system; single lab, two orthogonal methods (KD + ChIP)","pmids":["25528728"],"is_preprint":false},{"year":2014,"finding":"In erythroid cells, EKLF forms a novel HDAC complex (NuRSERY) containing HDAC5, GATA1, EKLF, and phospho-ERK (pERK); this complex is absent in megakaryocytic cells; ERK phosphorylation is required for complex formation and nuclear localization of HDAC5, GATA1, and EKLF.","method":"Pulldown/co-immunoprecipitation, ERK inhibitor treatment, Western blot analysis","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — co-IP identifying the complex plus pharmacological disruption; single lab, functional consequence partially inferred","pmids":["24594363"],"is_preprint":false},{"year":2017,"finding":"The British HPFH mutation (-198 T>C in the gamma-globin promoter) creates a de novo KLF1 binding site, and KLF1 directly binds this site to activate fetal globin expression; CRISPR introduction of -198 C into HUDEP-2 cells substantially elevates HbF.","method":"CRISPR/Cas9 genome editing, in vitro and in vivo binding assays, reporter assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — CRISPR functional edit plus direct binding assays; single lab, multiple orthogonal methods","pmids":["28659276"],"is_preprint":false},{"year":2017,"finding":"KLF1 directly activates ZBTB7A/LRF expression in erythroid cells by binding to the ZBTB7A proximal promoter; KLF1 also drives expression of a novel erythroid-specific ZBTB7A transcript, establishing ZBTB7A as a KLF1 target gene involved in gamma-globin repression.","method":"ChIP assay, promoter reporter assay, expression analysis","journal":"Blood advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP-confirmed direct binding plus reporter assay; single lab, two orthogonal methods","pmids":["29296711"],"is_preprint":false},{"year":2022,"finding":"EKLF/KLF1 acts as a pioneer transcription factor and regulates transcription through selective RNA polymerase II pause-release; in the Nan/+ mouse (EKLF-E339D variant), Nan-EKLF limits normal EKLF binding at a subset of sites and ectopically binds largely at enhancers, activating neomorphic target genes through pioneering and Pol II pause-release mechanisms.","method":"ChIP-seq in wild-type and Nan/+ mouse embryonic erythroid cells, GRO-seq/RNA Pol II occupancy analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP-seq with mechanistic comparison of normal vs. variant EKLF binding; single lab, rigorous genomic approach","pmids":["36543143"],"is_preprint":false},{"year":2000,"finding":"Correction of globin chain imbalance in EKLF-null embryos by gamma-globin transgene does not correct hemolysis or extend survival, establishing that nonglobin EKLF target genes are essential for definitive red blood cell function.","method":"Genetic complementation (gamma-globin transgene on EKLF-null background), hematological analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistatic rescue experiment showing that globin correction is insufficient; replicated in independent studies (PMID:9242564, PMID:16728274)","pmids":["10688844"],"is_preprint":false},{"year":2012,"finding":"EKLF directly activates the Klf3 gene, which then represses a subset of KLF1 target genes; KLF3 knockout mice exhibit impaired erythroid maturation, and KLF3 acts primarily as a feedback repressor countering EKLF activity at selected erythroid target genes.","method":"Klf3 knockout mouse analysis, microarray expression profiling, promoter analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO plus expression profiling; single lab, two complementary methods","pmids":["22711990"],"is_preprint":false},{"year":2012,"finding":"EKLF directly activates PIT1/SLC20A1 expression during RBC maturation by binding to the PIT1 promoter in vivo; shRNA depletion of either PIT1 or EKLF impairs erythroid maturation, and re-expression of PIT1 in EKLF-depleted cells partially restores maturation.","method":"ChIP assay (EKLF at PIT1 promoter), shRNA knockdown, epistatic rescue by PIT1 re-expression","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP plus shRNA KD plus epistatic rescue; single lab, multiple orthogonal methods","pmids":["23190530"],"is_preprint":false},{"year":2011,"finding":"KLF1 directly activates KLF2 expression and binds Myc promoters; KLF1 and KLF2 synergistically regulate Myc expression in embryonic erythroid cells; Myc ablation in embryonic proerythroblasts recapitulates KLF1/KLF2 double-KO anemia phenotype.","method":"Expression profiling, ChIP assay, genetic epistasis (Myc conditional KO in erythroid cells)","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus genetic epistasis; single lab, two methods","pmids":["22566683"],"is_preprint":false},{"year":2021,"finding":"EKLF/KLF1 expression defines a unique macrophage subset (erythroblastic island macrophages) during fetal liver erythropoiesis; single-cell sequencing identifies EKLF-dependent gene clusters and novel cell surface biomarkers specific to this macrophage population, which appears transiently during embryogenesis.","method":"Single-cell RNA-seq, global sequencing, genetic EKLF marking and KO analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Moderate — single-cell sequencing plus genetic KO and marking; single lab, multiple genomic methods","pmids":["33570494"],"is_preprint":false}],"current_model":"KLF1/EKLF is a zinc-finger transcription factor that functions as a master erythroid regulator: it binds CACCC/CACC elements via its three zinc fingers to directly activate a broad suite of erythroid genes (beta-globin, BCL11A, ZBTB7A/LRF, dematin, E2f2, p21, p18/p27, PIT1, and others), requires a SWI/SNF (E-RC1/BRG1) chromatin remodeling complex for chromatin opening at target loci, and is modulated by post-translational modifications including acetylation by CBP/p300 (at K288, toggling coactivator vs. corepressor interactions with Sin3A/HDAC1) and sumoylation by PIAS1 (enabling NuRD/Mi-2β repressor interactions to inhibit megakaryopoiesis); its transactivation domain interacts with TFIIH (Tfb1/p62) and CBP/p300 in a structurally defined manner; KLF1 controls hemoglobin switching both by directly activating beta-globin and by activating the gamma-globin repressors BCL11A and ZBTB7A; it regulates cell cycle progression (via E2f2, p21, p18/p27) to enable terminal erythroid differentiation and enucleation; it is expressed in and regulates erythroblastic island macrophages in a non-cell-autonomous role; and it antagonizes the megakaryocyte transcription factor FLI-1 to enforce erythroid over megakaryocyte lineage commitment."},"narrative":{"mechanistic_narrative":"KLF1 (EKLF) is the master transcriptional regulator of definitive erythropoiesis, coordinating nearly all aspects of terminal red cell maturation including globin production, heme biosynthesis, cell cycle exit, and membrane/cytoskeletal gene expression through genome-wide occupancy of CACCC/CACC elements [PMID:7753195, PMID:7753194, PMID:20508144, PMID:22835905]. It binds the beta-globin CACCC element via its zinc fingers, where thalassemia point mutations that weaken binding abolish transactivation, and it directly activates the locus control region site 5'HS3 [PMID:8288615, PMID:9744863]. KLF1 is embedded in the erythroid regulatory hierarchy downstream of GATA-1, which directly activates the EKLF promoter through a GATA-E box-GATA composite element, while KLF1 reciprocally interacts and synergizes with GATA-1 and stabilizes GATA-1/TAL1 occupancy, histone acetylation, and chromatin looping at target loci [PMID:7739528, PMID:8195185, PMID:9603943, PMID:10688820, PMID:18448565, PMID:25528728]. Productive activation requires recruitment of a SWI/SNF-related chromatin remodeling complex (E-RC1/BRG1) to open chromatin at target promoters, and KLF1 functions as a pioneer factor controlling RNA polymerase II pause-release [PMID:9778250, PMID:36543143]. KLF1 is a master switch for hemoglobin switching: it directly activates adult beta-globin while simultaneously activating the gamma-globin repressors BCL11A and ZBTB7A/LRF, and a British HPFH mutation creates a de novo KLF1 site that activates fetal globin [PMID:20676097, PMID:28659276, PMID:29296711]. It drives terminal differentiation by directly activating cell-cycle regulators E2f2, p21, and the CDK inhibitors p18/p27, the latter being required for cell cycle exit and enucleation [PMID:18852285, PMID:19457859, PMID:20368355, PMID:27480112]. KLF1 also enforces erythroid versus megakaryocyte lineage choice through mutual antagonism with FLI-1 and by repressing Fli-1, and it acts non-cell-autonomously in erythroblastic island macrophages by directly activating Dnase2a to enable degradation of extruded nuclei [PMID:12556498, PMID:17715392, PMID:21807894, PMID:33570494]. Its activity is tuned by post-translational modifications: CBP/p300 acetylation at K288 toggles coactivator versus Sin3A/HDAC1 corepressor interactions and is required for chromatin opening, while PIAS1-mediated sumoylation enables NuRD/Mi-2beta-dependent repression [PMID:15542849, PMID:17938210, PMID:18710946].","teleology":[{"year":1994,"claim":"Establishing how EKLF reaches its erythroid target and where it sits in the regulatory hierarchy was first addressed by defining its DNA element and its upstream activator.","evidence":"In vitro/in vivo binding and transactivation at the beta-globin CACCC element, and promoter dissection of the EKLF gene driven by GATA-1","pmids":["8288615","8195185"],"confidence":"High","gaps":["Did not address chromatin context or cofactor requirements for transactivation","Genome-wide target spectrum unknown at this stage"]},{"year":1995,"claim":"Whether EKLF is functionally essential and how it cooperates with other erythroid factors was resolved by knockout and physical interaction studies.","evidence":"EKLF knockout mice (fatal anemia, beta-globin deficit) and Co-IP/synergy assays with GATA-1","pmids":["7753195","7753194","7739528"],"confidence":"High","gaps":["Whether anemia stems from globin loss alone or other targets was unresolved","Mechanism of GATA-1/EKLF synergy on chromatin not defined"]},{"year":1996,"claim":"Dissection of the transactivation domain into stimulatory and inhibitory subdomains revealed that EKLF activity is conformationally gated and cofactor-dependent.","evidence":"Deletion/mutagenesis and DNA-binding competition assays of the proline-rich TAD","pmids":["8918466"],"confidence":"Medium","gaps":["Identity of the positive-acting cellular factor not defined here","Single-lab functional mapping without structural data"]},{"year":1998,"claim":"How EKLF mechanically activates transcription on chromatin and how it is post-translationally controlled was established through chromatin remodeling, acetylation, and phosphorylation studies.","evidence":"In vitro chromatin-template reconstitution with purified E-RC1/SWI/SNF complex, CBP/p300/P-CAF acetylation assays, CKII phosphorylation and mutagenesis, and transgenic 5'HS3 specificity assays","pmids":["9778250","9707565","9722526","9744863","9603943","10688820"],"confidence":"High","gaps":["Acetylated residue and its functional consequence not yet pinpointed","How PTMs integrate to switch activator/repressor states unresolved"]},{"year":2000,"claim":"Whether EKLF's essential role is reducible to globin regulation was tested by genetic complementation, establishing that non-globin targets are required for red cell function.","evidence":"Gamma-globin transgene complementation on EKLF-null background with hematological analysis","pmids":["10688844"],"confidence":"High","gaps":["The specific essential non-globin targets were not identified here"]},{"year":2003,"claim":"The basis of erythroid versus megakaryocyte lineage decision was clarified by demonstrating mutual transcriptional antagonism between EKLF and FLI-1.","evidence":"Co-IP, Gal4-domain mapping, and reciprocal reporter repression assays","pmids":["12556498"],"confidence":"High","gaps":["In vivo lineage consequences of the antagonism not measured in this study"]},{"year":2004,"claim":"How EKLF can both activate and repress was resolved by linking its acetylation status to a choice between coactivators and Sin3A/HDAC1 corepressors.","evidence":"Co-IP, point mutagenesis of a key lysine, and stage-specific repression assays","pmids":["15542849"],"confidence":"High","gaps":["How stage-specific signals dictate acetylation state in vivo not defined"]},{"year":2006,"claim":"EKLF protein turnover was characterized, showing it is a short-lived, proteasome-degraded factor.","evidence":"Proteasome inhibition, in vivo ubiquitination, pulse-chase stability, and PEST mutagenesis","pmids":["16579989"],"confidence":"Medium","gaps":["The responsible E3 ligase was not identified","Physiological signals controlling turnover unknown"]},{"year":2008,"claim":"EKLF's roles in cell cycle progression, in transcriptional networks with other KLFs, in repression via sumoylation, and in upstream induction were defined through ChIP, genetic, and PTM studies.","evidence":"ChIP at E2f2 promoter with cell-cycle phenotyping, KLF3 promoter competition with Klf3-KO analysis, PIAS1-mediated sumoylation/NuRD co-IP, K288 acetylation ChIP rescue, Gata2/Smad5-driven Eklf induction, and demonstration of a cytoplasmic EKLF pool","pmids":["18852285","18687676","17938210","18710946","18448565","18329016"],"confidence":"High","gaps":["Functional role of the cytoplasmic EKLF pool not established","How acetylation/sumoylation are coordinated in vivo unresolved"]},{"year":2009,"claim":"Direct genetic linkage between EKLF, E2f2, and cell cycle entry was established, and EKLF was shown to act as a gamma-globin co-activator under SCFA induction.","evidence":"ChIP at E2f2 intronic enhancers with Rb-knockout epistasis rescue, and EKLF/BRG1 recruitment at the gamma-globin promoter","pmids":["19457859","19220418"],"confidence":"High","gaps":["Context-dependence of EKLF acting at gamma-globin versus repressing it via BCL11A not reconciled here"]},{"year":2010,"claim":"Genome-wide occupancy and the globin-switching mechanism were defined, establishing KLF1 as a global activator and a dual controller of hemoglobin switching.","evidence":"KLF1 ChIP-seq in primary fetal liver erythroid cells, BCL11A knockdown studies, p21 ChIP/reporter assays, dematin/cytoskeletal target profiling, and c-Myb-driven KLF1 activation","pmids":["20508144","20676097","20368355","16380451","20686118"],"confidence":"High","gaps":["Direct functional dissection of most of the >945 binding sites not performed","Hierarchy among the many activated programs not ranked"]},{"year":2011,"claim":"The structural basis of TAD-cofactor contacts, KLF1's role in macrophage Dnase2a regulation, and synergy with KLF2 at Myc were defined.","evidence":"NMR structure of EKLFTAD2/Tfb1PH with CBP/p300 binding, ChIP at the macrophage Dnase2a promoter with KO analysis, and KLF1/KLF2 ChIP/Myc epistasis","pmids":["21670263","21807894","22566683"],"confidence":"High","gaps":["Structural model limited to TAD2/Tfb1PH; full coactivator complex geometry unknown","Non-cell-autonomous macrophage contribution not quantitatively separated from intrinsic role"]},{"year":2012,"claim":"Integrated transcriptomic and genetic studies extended KLF1's regulatory reach to a cis-regulatory module shared with GATA1/TAL1/EP300, to feedback repressor KLF3, and to PIT1.","evidence":"mRNA-seq of Klf1+/+ vs Klf1-/- integrated with ChIP-seq, Klf3-KO profiling, and PIT1 ChIP/shRNA/rescue","pmids":["22835905","22711990","23190530"],"confidence":"High","gaps":["Functional roles of KLF1-dependent lncRNAs not characterized","How activating and repressive KLF subnetworks balance quantitatively unresolved"]},{"year":2014,"claim":"KLF1's mechanism of stabilizing partner-factor occupancy, its assembly into an HDAC (NuRSERY) complex, and its macrophage-extrinsic role were further detailed.","evidence":"ChIP after KLF1 knockdown showing reduced GATA-1/TAL1 binding, NuRSERY complex Co-IP with ERK-dependence, and embryoid-body island formation with EKLF macrophage marking","pmids":["25528728","24594363","24866116"],"confidence":"Medium","gaps":["NuRSERY complex functional output partially inferred from pharmacology","Mechanism by which KLF1 stabilizes partner occupancy not structurally defined"]},{"year":2016,"claim":"The causal link between KLF1-controlled cell cycle exit and enucleation was established by epistatic rescue.","evidence":"Imaging flow cytometry of terminal differentiation with p18/p27 reintroduction rescue in EKLF-deficient cells","pmids":["27480112"],"confidence":"High","gaps":["Direct ChIP occupancy at p18/p27 loci not the focus of this study","Mechanical link between cell cycle exit and nuclear extrusion machinery not defined"]},{"year":2017,"claim":"Direct activation of the gamma-globin repressor ZBTB7A and the gain-of-binding HPFH mechanism cemented KLF1's central role in fetal-to-adult globin switching.","evidence":"ZBTB7A promoter ChIP/reporter assays and CRISPR introduction of the -198 T>C gamma-globin promoter variant in HUDEP-2 cells","pmids":["29296711","28659276"],"confidence":"Medium","gaps":["Quantitative contribution of ZBTB7A vs BCL11A to switching not resolved here"]},{"year":2021,"claim":"Single-cell profiling defined KLF1-expressing erythroblastic island macrophages as a discrete transient population with KLF1-dependent gene clusters.","evidence":"Single-cell RNA-seq with genetic EKLF marking and KO analysis in fetal liver","pmids":["33570494"],"confidence":"High","gaps":["Functional necessity of individual KLF1-dependent macrophage genes for island integrity not dissected"]},{"year":2022,"claim":"KLF1 was defined as a pioneer factor acting through Pol II pause-release, and the Nan/+ variant was shown to drive neomorphic binding and target activation.","evidence":"ChIP-seq and GRO-seq/Pol II occupancy in wild-type and Nan/+ (E339D) erythroid cells","pmids":["36543143"],"confidence":"High","gaps":["Generalizability of pioneering across all KLF1 sites not established","Molecular basis of Nan-EKLF enhancer redirection not fully defined"]},{"year":null,"claim":"How the many KLF1 post-translational modifications, partner-stabilizing functions, and pioneering activity are integrated in real time to switch between activator and repressor states across erythroid maturation stages remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking acetylation, sumoylation, phosphorylation, and turnover to stage-specific output","Quantitative hierarchy among hundreds of direct targets undefined","E3 ligase and signaling control of KLF1 abundance unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,16,21,31,37]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,9,21,35]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[21,25]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[25]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,21,31]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,13,26,38]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[14,15,22,26]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[5,18,37]}],"complexes":["E-RC1 (SWI/SNF/BRG1)","NuRSERY (HDAC5/GATA1/EKLF/pERK)","NuRD (Mi-2beta)"],"partners":["GATA1","BRG1","CBP","EP300","FLI1","PIAS1","TAL1","SIN3A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q13351","full_name":"Krueppel-like factor 1","aliases":["Erythroid krueppel-like transcription factor","EKLF"],"length_aa":362,"mass_kda":38.2,"function":"Transcription regulator of erythrocyte development that probably serves as a general switch factor during erythropoiesis. Is a dual regulator of fetal-to-adult globin switching. Binds to the CACCC box in the beta-globin gene promoter and acts as a preferential activator of this gene. Furthermore, it binds to the BCL11A promoter and activates expression of BCL11A, which in turn represses the HBG1 and HBG2 genes. This dual activity ensures that, in most adults, fetal hemoglobin levels are low. Able to activate CD44 and AQP1 promoters (PubMed:21055716). When sumoylated, acts as a transcriptional repressor by promoting interaction with CDH2/MI2beta and also represses megakaryocytic differentiation","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q13351/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KLF1","classification":"Not Classified","n_dependent_lines":27,"n_total_lines":1208,"dependency_fraction":0.022350993377483443},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KLF1","total_profiled":1310},"omim":[{"mim_id":"621229","title":"GATA2 ANTISENSE RNA 1, NONCODING; GATA2AS1","url":"https://www.omim.org/entry/621229"},{"mim_id":"621019","title":"PRE-mRNA-PROCESSING FACTOR 40 HOMOLOG B; PRPF40B","url":"https://www.omim.org/entry/621019"},{"mim_id":"620969","title":"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IVb; CDAN4B","url":"https://www.omim.org/entry/620969"},{"mim_id":"613673","title":"ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IVa; CDAN4A","url":"https://www.omim.org/entry/613673"},{"mim_id":"613566","title":"FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6; HBFQTL6","url":"https://www.omim.org/entry/613566"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"bone marrow","ntpm":38.8}],"url":"https://www.proteinatlas.org/search/KLF1"},"hgnc":{"alias_symbol":["EKLF"],"prev_symbol":[]},"alphafold":{"accession":"Q13351","domains":[{"cath_id":"3.30.160,3.30.160","chopping":"277-307","consensus_level":"medium","plddt":79.7445,"start":277,"end":307}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13351","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13351-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13351-F1-predicted_aligned_error_v6.png","plddt_mean":56.97},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KLF1","jax_strain_url":"https://www.jax.org/strain/search?query=KLF1"},"sequence":{"accession":"Q13351","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13351.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13351/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13351"}},"corpus_meta":[{"pmid":"7753195","id":"PMC_7753195","title":"Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7753195","citation_count":536,"is_preprint":false},{"pmid":"7753194","id":"PMC_7753194","title":"Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene.","date":"1995","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/7753194","citation_count":496,"is_preprint":false},{"pmid":"7739528","id":"PMC_7739528","title":"Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Krüppel family proteins Sp1 and EKLF.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7739528","citation_count":430,"is_preprint":false},{"pmid":"9707565","id":"PMC_9707565","title":"Acetylation and modulation of erythroid Krüppel-like factor (EKLF) activity by interaction with histone acetyltransferases.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9707565","citation_count":320,"is_preprint":false},{"pmid":"20676097","id":"PMC_20676097","title":"KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching.","date":"2010","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20676097","citation_count":320,"is_preprint":false},{"pmid":"9778250","id":"PMC_9778250","title":"A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro.","date":"1998","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9778250","citation_count":265,"is_preprint":false},{"pmid":"21613252","id":"PMC_21613252","title":"The multifunctional role of EKLF/KLF1 during erythropoiesis.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21613252","citation_count":260,"is_preprint":false},{"pmid":"20508144","id":"PMC_20508144","title":"A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells.","date":"2010","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/20508144","citation_count":191,"is_preprint":false},{"pmid":"8918890","id":"PMC_8918890","title":"The role of EKLF in human beta-globin gene competition.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8918890","citation_count":180,"is_preprint":false},{"pmid":"16380451","id":"PMC_16380451","title":"A global role for EKLF in definitive and primitive erythropoiesis.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16380451","citation_count":176,"is_preprint":false},{"pmid":"8288615","id":"PMC_8288615","title":"Analyses of beta-thalassemia mutant DNA interactions with erythroid Krüppel-like factor (EKLF), an erythroid cell-specific transcription factor.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8288615","citation_count":167,"is_preprint":false},{"pmid":"21055716","id":"PMC_21055716","title":"A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia.","date":"2010","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21055716","citation_count":159,"is_preprint":false},{"pmid":"24829204","id":"PMC_24829204","title":"KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24829204","citation_count":138,"is_preprint":false},{"pmid":"15923635","id":"PMC_15923635","title":"The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15923635","citation_count":135,"is_preprint":false},{"pmid":"26903544","id":"PMC_26903544","title":"Krüppeling erythropoiesis: an unexpected broad spectrum of human red blood cell disorders due to KLF1 variants.","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/26903544","citation_count":134,"is_preprint":false},{"pmid":"8901569","id":"PMC_8901569","title":"Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8901569","citation_count":129,"is_preprint":false},{"pmid":"18487511","id":"PMC_18487511","title":"Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18487511","citation_count":123,"is_preprint":false},{"pmid":"12556498","id":"PMC_12556498","title":"Functional cross-antagonism between transcription factors FLI-1 and EKLF.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12556498","citation_count":114,"is_preprint":false},{"pmid":"17715392","id":"PMC_17715392","title":"Novel role for EKLF in megakaryocyte lineage commitment.","date":"2007","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/17715392","citation_count":110,"is_preprint":false},{"pmid":"8195185","id":"PMC_8195185","title":"Regulation of the erythroid Kruppel-like factor (EKLF) gene promoter by the erythroid transcription factor GATA-1.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8195185","citation_count":103,"is_preprint":false},{"pmid":"23237380","id":"PMC_23237380","title":"Prediction of novel long non-coding RNAs based on RNA-Seq data of mouse Klf1 knockout study.","date":"2012","source":"BMC bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/23237380","citation_count":96,"is_preprint":false},{"pmid":"20686118","id":"PMC_20686118","title":"c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20686118","citation_count":93,"is_preprint":false},{"pmid":"22835905","id":"PMC_22835905","title":"Novel roles for KLF1 in erythropoiesis revealed by mRNA-seq.","date":"2012","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/22835905","citation_count":92,"is_preprint":false},{"pmid":"21821711","id":"PMC_21821711","title":"KLF1 gene mutations cause borderline HbA(2).","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21821711","citation_count":91,"is_preprint":false},{"pmid":"18687676","id":"PMC_18687676","title":"A network of Krüppel-like Factors (Klfs). Klf8 is repressed by Klf3 and activated by Klf1 in vivo.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18687676","citation_count":91,"is_preprint":false},{"pmid":"18852285","id":"PMC_18852285","title":"Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18852285","citation_count":87,"is_preprint":false},{"pmid":"28659276","id":"PMC_28659276","title":"KLF1 drives the expression of fetal hemoglobin in British HPFH.","date":"2017","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/28659276","citation_count":79,"is_preprint":false},{"pmid":"11807044","id":"PMC_11807044","title":"The BMP/BMPR/Smad pathway directs expression of the erythroid-specific EKLF and GATA1 transcription factors during embryoid body differentiation in serum-free media.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11807044","citation_count":78,"is_preprint":false},{"pmid":"8924208","id":"PMC_8924208","title":"Isolation, genomic structure, and expression of human erythroid Krüppel-like factor (EKLF).","date":"1996","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/8924208","citation_count":77,"is_preprint":false},{"pmid":"25724378","id":"PMC_25724378","title":"KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome.","date":"2015","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25724378","citation_count":77,"is_preprint":false},{"pmid":"27480112","id":"PMC_27480112","title":"EKLF/KLF1-regulated cell cycle exit is essential for erythroblast enucleation.","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/27480112","citation_count":75,"is_preprint":false},{"pmid":"18523154","id":"PMC_18523154","title":"EKLF restricts megakaryocytic differentiation at the benefit of erythrocytic differentiation.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18523154","citation_count":75,"is_preprint":false},{"pmid":"11238130","id":"PMC_11238130","title":"Erythroid Kruppel-like factor (EKLF) coordinates erythroid cell proliferation and hemoglobinization in cell lines derived from EKLF null mice.","date":"2001","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11238130","citation_count":73,"is_preprint":false},{"pmid":"23090966","id":"PMC_23090966","title":"EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23090966","citation_count":70,"is_preprint":false},{"pmid":"21190291","id":"PMC_21190291","title":"KLF1 directly coordinates almost all aspects of terminal erythroid differentiation.","date":"2010","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/21190291","citation_count":69,"is_preprint":false},{"pmid":"9545245","id":"PMC_9545245","title":"Erythroid Krüppel-like factor (EKLF) is active in primitive and definitive erythroid cells and is required for the function of 5'HS3 of the beta-globin locus control region.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9545245","citation_count":67,"is_preprint":false},{"pmid":"19457859","id":"PMC_19457859","title":"EKLF/KLF1 controls cell cycle entry via direct regulation of E2f2.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19457859","citation_count":66,"is_preprint":false},{"pmid":"11069894","id":"PMC_11069894","title":"Context-dependent EKLF responsiveness defines the developmental specificity of the human epsilon-globin gene in erythroid cells of YAC transgenic mice.","date":"2000","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11069894","citation_count":65,"is_preprint":false},{"pmid":"21273267","id":"PMC_21273267","title":"Compound heterozygosity for KLF1 mutations associated with remarkable increase of fetal hemoglobin and red cell protoporphyrin.","date":"2011","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/21273267","citation_count":64,"is_preprint":false},{"pmid":"22102705","id":"PMC_22102705","title":"Ten novel mutations in the erythroid transcription factor KLF1 gene associated with increased fetal hemoglobin levels in adults.","date":"2011","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/22102705","citation_count":64,"is_preprint":false},{"pmid":"17938210","id":"PMC_17938210","title":"Sumoylation of EKLF promotes transcriptional repression and is involved in inhibition of megakaryopoiesis.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17938210","citation_count":63,"is_preprint":false},{"pmid":"15542849","id":"PMC_15542849","title":"Stage-specific repression by the EKLF transcriptional activator.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15542849","citation_count":63,"is_preprint":false},{"pmid":"23522491","id":"PMC_23522491","title":"Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: review of all reported cases and development of a clinical diagnostic paradigm.","date":"2013","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/23522491","citation_count":61,"is_preprint":false},{"pmid":"9603943","id":"PMC_9603943","title":"Multiple proteins binding to a GATA-E box-GATA motif regulate the erythroid Krüppel-like factor (EKLF) gene.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9603943","citation_count":60,"is_preprint":false},{"pmid":"8918466","id":"PMC_8918466","title":"Erythroid Krüppel-like factor (EKLF) contains a multifunctional transcriptional activation domain important for inter- and intramolecular interactions.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8918466","citation_count":58,"is_preprint":false},{"pmid":"9744863","id":"PMC_9744863","title":"Altered DNA-binding specificity mutants of EKLF and Sp1 show that EKLF is an activator of the beta-globin locus control region in vivo.","date":"1998","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9744863","citation_count":55,"is_preprint":false},{"pmid":"18448565","id":"PMC_18448565","title":"Activation of Eklf expression during hematopoiesis by Gata2 and Smad5 prior to erythroid commitment.","date":"2008","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18448565","citation_count":51,"is_preprint":false},{"pmid":"9722526","id":"PMC_9722526","title":"Regulation of erythroid Krüppel-like factor (EKLF) transcriptional activity by phosphorylation of a protein kinase casein kinase II site within its interaction domain.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9722526","citation_count":51,"is_preprint":false},{"pmid":"21670263","id":"PMC_21670263","title":"Structural and functional characterization of an atypical activation domain in erythroid Kruppel-like factor (EKLF).","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21670263","citation_count":50,"is_preprint":false},{"pmid":"32576837","id":"PMC_32576837","title":"Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34+ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32576837","citation_count":49,"is_preprint":false},{"pmid":"27056246","id":"PMC_27056246","title":"Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease.","date":"2016","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27056246","citation_count":49,"is_preprint":false},{"pmid":"29296711","id":"PMC_29296711","title":"KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A/LRF in erythroid cells.","date":"2017","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/29296711","citation_count":48,"is_preprint":false},{"pmid":"25107887","id":"PMC_25107887","title":"Induction of adult levels of β-globin in human erythroid cells that intrinsically express embryonic or fetal globin by transduction with KLF1 and BCL11A-XL.","date":"2014","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/25107887","citation_count":47,"is_preprint":false},{"pmid":"10688844","id":"PMC_10688844","title":"Fetal expression of a human Agamma globin transgene rescues globin chain imbalance but not hemolysis in EKLF null mouse embryos.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10688844","citation_count":46,"is_preprint":false},{"pmid":"23361909","id":"PMC_23361909","title":"Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23361909","citation_count":45,"is_preprint":false},{"pmid":"28157724","id":"PMC_28157724","title":"Orchestration of late events in erythropoiesis by KLF1/EKLF.","date":"2017","source":"Current opinion in hematology","url":"https://pubmed.ncbi.nlm.nih.gov/28157724","citation_count":43,"is_preprint":false},{"pmid":"28026072","id":"PMC_28026072","title":"Activation of KLF1 Enhances the Differentiation and Maturation of Red Blood Cells from Human Pluripotent Stem Cells.","date":"2017","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/28026072","citation_count":43,"is_preprint":false},{"pmid":"25976964","id":"PMC_25976964","title":"Krüppel-like factor 1: hematologic phenotypes associated with KLF1 gene mutations.","date":"2015","source":"International journal of laboratory hematology","url":"https://pubmed.ncbi.nlm.nih.gov/25976964","citation_count":42,"is_preprint":false},{"pmid":"27668420","id":"PMC_27668420","title":"Genetic disruption of the KLF1 gene to overexpress the γ-globin gene using the CRISPR/Cas9 system.","date":"2016","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27668420","citation_count":42,"is_preprint":false},{"pmid":"10688820","id":"PMC_10688820","title":"The GATA-E box-GATA motif in the EKLF promoter is required for in vivo expression.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10688820","citation_count":42,"is_preprint":false},{"pmid":"21778342","id":"PMC_21778342","title":"Mutations in the second zinc finger of human EKLF reduce promoter affinity but give rise to benign and disease phenotypes.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21778342","citation_count":42,"is_preprint":false},{"pmid":"16728274","id":"PMC_16728274","title":"Major erythrocyte membrane protein genes in EKLF-deficient mice.","date":"2006","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/16728274","citation_count":41,"is_preprint":false},{"pmid":"21807894","id":"PMC_21807894","title":"Klf1 affects DNase II-alpha expression in the central macrophage of a fetal liver erythroblastic island: a non-cell-autonomous role in definitive erythropoiesis.","date":"2011","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21807894","citation_count":41,"is_preprint":false},{"pmid":"35609331","id":"PMC_35609331","title":"Knockdown of lncRNA PCAT6 suppresses the growth of non-small cell lung cancer cells by inhibiting macrophages M2 polarization via miR-326/KLF1 axis.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/35609331","citation_count":40,"is_preprint":false},{"pmid":"22711990","id":"PMC_22711990","title":"The CACCC-binding protein KLF3/BKLF represses a subset of KLF1/EKLF target genes and is required for proper erythroid maturation in vivo.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22711990","citation_count":39,"is_preprint":false},{"pmid":"21610079","id":"PMC_21610079","title":"Transcription factors KLF1 and KLF2 positively regulate embryonic and fetal beta-globin genes through direct promoter binding.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21610079","citation_count":39,"is_preprint":false},{"pmid":"20691777","id":"PMC_20691777","title":"Mutation in erythroid specific transcription factor KLF1 causes Hereditary Spherocytosis in the Nan hemolytic anemia mouse model.","date":"2010","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/20691777","citation_count":38,"is_preprint":false},{"pmid":"9242564","id":"PMC_9242564","title":"A shortened life span of EKLF-/- adult erythrocytes, due to a deficiency of beta-globin chains, is ameliorated by human gamma-globin chains.","date":"1997","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/9242564","citation_count":37,"is_preprint":false},{"pmid":"22566683","id":"PMC_22566683","title":"Kruppel-like factor 1 (KLF1), KLF2, and Myc control a regulatory network essential for embryonic erythropoiesis.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22566683","citation_count":36,"is_preprint":false},{"pmid":"19850899","id":"PMC_19850899","title":"Megakaryocyte-erythroid lineage promiscuity in EKLF null mouse blood.","date":"2009","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/19850899","citation_count":36,"is_preprint":false},{"pmid":"20720183","id":"PMC_20720183","title":"Dose-dependent regulation of primitive erythroid maturation and identity by the transcription factor Eklf.","date":"2010","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/20720183","citation_count":36,"is_preprint":false},{"pmid":"15516974","id":"PMC_15516974","title":"Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15516974","citation_count":34,"is_preprint":false},{"pmid":"20368355","id":"PMC_20368355","title":"EKLF directly activates the p21WAF1/CIP1 gene by proximal promoter and novel intronic regulatory regions during erythroid differentiation.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20368355","citation_count":33,"is_preprint":false},{"pmid":"24866116","id":"PMC_24866116","title":"Extrinsic and intrinsic control by EKLF (KLF1) within a specialized erythroid niche.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/24866116","citation_count":32,"is_preprint":false},{"pmid":"15352994","id":"PMC_15352994","title":"A novel silent beta-thalassemia mutation in the distal CACCC box affects the binding and responsiveness to EKLF.","date":"2004","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/15352994","citation_count":31,"is_preprint":false},{"pmid":"18710946","id":"PMC_18710946","title":"Acetylation of EKLF is essential for epigenetic modification and transcriptional activation of the beta-globin locus.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18710946","citation_count":30,"is_preprint":false},{"pmid":"19097174","id":"PMC_19097174","title":"Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia.","date":"2009","source":"American journal of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/19097174","citation_count":29,"is_preprint":false},{"pmid":"9737959","id":"PMC_9737959","title":"Chromatin structure and transcriptional control elements of the erythroid Krüppel-like factor (EKLF) gene.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9737959","citation_count":29,"is_preprint":false},{"pmid":"31346165","id":"PMC_31346165","title":"KLF-1 orchestrates a xenobiotic detoxification program essential for longevity of mitochondrial mutants.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31346165","citation_count":29,"is_preprint":false},{"pmid":"25585695","id":"PMC_25585695","title":"Compound heterozygosity for KLF1 mutations is associated with microcytic hypochromic anemia and increased fetal hemoglobin.","date":"2015","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/25585695","citation_count":29,"is_preprint":false},{"pmid":"25528728","id":"PMC_25528728","title":"KLF1 stabilizes GATA-1 and TAL1 occupancy in the human β-globin locus.","date":"2014","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/25528728","citation_count":27,"is_preprint":false},{"pmid":"24594363","id":"PMC_24594363","title":"Identification of NuRSERY, a new functional HDAC complex composed by HDAC5, GATA1, EKLF and pERK present in human erythroid cells.","date":"2014","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24594363","citation_count":27,"is_preprint":false},{"pmid":"33570494","id":"PMC_33570494","title":"EKLF/KLF1 expression defines a unique macrophage subset during mouse erythropoiesis.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33570494","citation_count":26,"is_preprint":false},{"pmid":"14764531","id":"PMC_14764531","title":"Regulatory elements of the EKLF gene that direct erythroid cell-specific expression during mammalian development.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/14764531","citation_count":26,"is_preprint":false},{"pmid":"19220418","id":"PMC_19220418","title":"Erythroid Kruppel-like factor (EKLF) is recruited to the gamma-globin gene promoter as a co-activator and is required for gamma-globin gene induction by short-chain fatty acid derivatives.","date":"2009","source":"European journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/19220418","citation_count":26,"is_preprint":false},{"pmid":"23190530","id":"PMC_23190530","title":"EKLF-driven PIT1 expression is critical for mouse erythroid maturation in vivo and in vitro.","date":"2012","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23190530","citation_count":25,"is_preprint":false},{"pmid":"29601850","id":"PMC_29601850","title":"miR-326 regulates HbF synthesis by targeting EKLF in human erythroid cells.","date":"2018","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/29601850","citation_count":25,"is_preprint":false},{"pmid":"9726989","id":"PMC_9726989","title":"Transcription factor erythroid Krüppel-like factor (EKLF) is essential for the erythropoietin-induced hemoglobin production but not for proliferation, viability, or morphological maturation.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9726989","citation_count":25,"is_preprint":false},{"pmid":"16579989","id":"PMC_16579989","title":"EKLF/KLF1 is ubiquitinated in vivo and its stability is regulated by activation domain sequences through the 26S proteasome.","date":"2006","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/16579989","citation_count":23,"is_preprint":false},{"pmid":"22093801","id":"PMC_22093801","title":"Delayed fetal hemoglobin switching in subjects with KLF1 gene mutation.","date":"2011","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/22093801","citation_count":23,"is_preprint":false},{"pmid":"4556462","id":"PMC_4556462","title":"Genetic and physicochemical characterization of Escherichia coli strains carrying fused F' elements derived from KLF1 and F57.","date":"1972","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/4556462","citation_count":22,"is_preprint":false},{"pmid":"36543143","id":"PMC_36543143","title":"EKLF/Klf1 regulates erythroid transcription by its pioneering activity and selective control of RNA Pol II pause-release.","date":"2022","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/36543143","citation_count":21,"is_preprint":false},{"pmid":"28143845","id":"PMC_28143845","title":"Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28143845","citation_count":21,"is_preprint":false},{"pmid":"25150253","id":"PMC_25150253","title":"Krüppel-like transcription factors KLF1 and KLF2 have unique and coordinate roles in regulating embryonic erythroid precursor maturation.","date":"2014","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/25150253","citation_count":21,"is_preprint":false},{"pmid":"24167631","id":"PMC_24167631","title":"Klf1, a C2H2 zinc finger-transcription factor, is required for cell wall maintenance during long-term quiescence in differentiated G0 phase.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24167631","citation_count":21,"is_preprint":false},{"pmid":"30872368","id":"PMC_30872368","title":"Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient.","date":"2019","source":"Haematologica","url":"https://pubmed.ncbi.nlm.nih.gov/30872368","citation_count":20,"is_preprint":false},{"pmid":"18329016","id":"PMC_18329016","title":"Non-random subcellular distribution of variant EKLF in erythroid cells.","date":"2008","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/18329016","citation_count":20,"is_preprint":false},{"pmid":"30876823","id":"PMC_30876823","title":"KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells.","date":"2019","source":"Experimental hematology","url":"https://pubmed.ncbi.nlm.nih.gov/30876823","citation_count":20,"is_preprint":false},{"pmid":"23161389","id":"PMC_23161389","title":"Functional analysis of a novel KLF1 gene promoter variation associated with hereditary persistence of fetal hemoglobin.","date":"2012","source":"Annals of hematology","url":"https://pubmed.ncbi.nlm.nih.gov/23161389","citation_count":20,"is_preprint":false},{"pmid":"30529538","id":"PMC_30529538","title":"Differential role of Kruppel like factor 1 (KLF1) gene in red blood cell disorders.","date":"2018","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/30529538","citation_count":19,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45743,"output_tokens":10146,"usd":0.144709,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":20410,"output_tokens":5752,"usd":0.122925,"stage2_stop_reason":"end_turn"},"total_usd":0.267634,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"EKLF/KLF1 knockout mice die of anemia during fetal liver erythropoiesis with specific deficit in beta-globin gene expression, establishing that EKLF is required for definitive erythropoiesis and beta-globin activation but is dispensable for yolk sac erythropoiesis and erythroid commitment.\",\n      \"method\": \"Gene targeting (knockout mouse), hematological and molecular phenotyping\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — independently replicated in two simultaneous knockout studies (PMID:7753195 and PMID:7753194), clean loss-of-function with defined molecular phenotype\",\n      \"pmids\": [\"7753195\", \"7753194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"EKLF binds the CACCC element in the beta-globin promoter via its zinc finger domain; beta-thalassemia point mutations in the CAC site reduce EKLF binding affinity 40–100-fold and abolish EKLF-dependent transactivation, demonstrating that EKLF binding to CACCC is essential for beta-globin transcription.\",\n      \"method\": \"In vivo reporter transactivation assays, in vitro DNA binding affinity measurements, molecular modeling based on Zif268/DNA co-crystal structure\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro binding assays combined with in vivo transactivation, replicated across multiple mutants, mechanistic mutagenesis data\",\n      \"pmids\": [\"8288615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"EKLF physically interacts with the erythroid transcription factor GATA-1 through their respective DNA-binding domains; GATA-1 and EKLF synergize to activate transcription, providing a mechanism for erythroid-specific gene regulation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assays, co-transfection transcriptional synergy assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal physical interaction demonstrated in vitro and in vivo with functional synergy assays; replicated in multiple experimental systems within the same study\",\n      \"pmids\": [\"7739528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"GATA-1 directly activates the EKLF gene promoter through a GATA motif at position -60; GATA-1 binding sites and CP1 sites are both required for full EKLF promoter activity, placing EKLF downstream of GATA-1 in the erythroid regulatory hierarchy.\",\n      \"method\": \"Promoter deletion/mutation analysis, co-transfection assays, DNA binding assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional promoter dissection combined with co-transfection rescue experiments; replicated and extended in later studies (PMID:8603943, PMID:10688820)\",\n      \"pmids\": [\"8195185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"EKLF is acetylated in vivo and interacts with histone acetyltransferases CBP, p300, and P/CAF; CBP and p300 (but not P/CAF) acetylate EKLF within its transactivation domain and enhance EKLF-dependent beta-globin transcription in erythroid cells.\",\n      \"method\": \"In vivo co-immunoprecipitation, in vitro acetylation assay, co-transfection transcriptional activation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro enzymatic acetylation assay combined with in vivo co-IP and functional transcription assays; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"9707565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"EKLF requires a SWI/SNF-related chromatin remodeling complex (E-RC1, containing BRG1, BAF170, BAF155, INI1, and BAF57) to remodel chromatin at the beta-globin promoter and activate transcription in vitro; this interaction is transcription-factor selective.\",\n      \"method\": \"In vitro chromatin-assembled transcription assay, biochemical purification of E-RC1 complex, functional reconstitution\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution on chromatin templates in vitro with purified complex, multiple subunit identification; single lab but rigorous biochemistry\",\n      \"pmids\": [\"9778250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"EKLF is phosphorylated at serine and threonine residues within its transactivation region; casein kinase II (CKIIα) interacts with EKLF and phosphorylates Thr-41 within the EKLF interaction domain, and mutation of this CKII site abolishes EKLF transactivation activity.\",\n      \"method\": \"In vivo phosphorylation analysis, in vitro kinase assay, site-directed mutagenesis, co-transfection transcriptional assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay plus mutagenesis plus in vivo functional assay, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"9722526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"EKLF's proline-rich transactivation domain contains discrete stimulatory and inhibitory subdomains; the inhibitory domain suppresses DNA binding in cis, while a 40 amino acid minimal transactivation domain mediates trans-interaction with a positive-acting cellular factor, and phosphorylation/conformation of this core is critical for these interactions.\",\n      \"method\": \"Deletion/mutagenesis co-transfection assays, in vitro DNA binding competition assays, in vivo competition assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional mutagenesis plus in vitro and in vivo binding/competition assays; single lab, multiple methods\",\n      \"pmids\": [\"8918466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The mouse EKLF promoter contains a GATA-E box-GATA composite element in which GATA-1 binds both GATA sites and another erythroid factor binds the central E box; all three sites act as a unit (not additively) to drive erythroid-specific EKLF expression in transgenic mice.\",\n      \"method\": \"Transgenic mouse reporter assays, in vitro DNA binding/gel-shift assays, promoter mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic in vivo validation combined with in vitro binding assays; confirmed in follow-up transgenic study (PMID:10688820)\",\n      \"pmids\": [\"9603943\", \"10688820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"EKLF activates the beta-globin locus control region hypersensitive site 5'HS3 in vivo, as demonstrated by matching point mutations in 5'HS3 CACCC motifs with amino acid substitutions in EKLF zinc fingers that alter DNA-binding specificity.\",\n      \"method\": \"Altered DNA-binding specificity approach (matched mutations in DNA site and zinc finger), transgenic mouse assay\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — elegant genetic specificity experiment in vivo using matched mutations; single lab but rigorous in vivo validation\",\n      \"pmids\": [\"9744863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"EKLF functions as a stage-specific transcriptional repressor in addition to an activator; it interacts with Sin3A and HDAC1 corepressors via its zinc finger domain, and a key lysine residue serves as both a CBP acetylation substrate and a Sin3A interaction site, linking acetylation status to coactivator vs. corepressor choice.\",\n      \"method\": \"Co-immunoprecipitation, point mutagenesis, in vivo transcriptional repression assays, stage-specific erythroid cell assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP plus mutagenesis plus functional transcription assays; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"15542849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"EKLF is post-translationally modified by sumoylation at a single site near its amino terminus; PIAS1 is the SUMO E3 ligase for this modification. Sumoylation is required for EKLF's repressive (not activating) function through a SUMO-dependent interaction with the Mi-2β component of the NuRD repression complex, and is important for inhibiting megakaryocyte differentiation.\",\n      \"method\": \"In vivo sumoylation assay, site-directed mutagenesis, co-immunoprecipitation, gain/loss-of-function transcriptional and lineage differentiation assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo modification plus co-IP of NuRD complex plus mutagenesis plus lineage functional assay; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"17938210\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"FLI-1 represses EKLF-dependent transcription by interacting with EKLF (via FLI-1 N- and C-terminal domains) and recruiting the repressive FLI-1 ETS domain to erythroid promoters; reciprocally, EKLF represses the FLI-1-dependent megakaryocytic GPIX promoter, establishing functional cross-antagonism that controls erythroid vs. megakaryocytic lineage choice.\",\n      \"method\": \"Co-immunoprecipitation, reporter gene transcription assays, Gal4-fusion domain analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — physical interaction plus reciprocal functional repression assays; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"12556498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"EKLF plays a directive role in megakaryocyte-erythroid progenitor lineage commitment: EKLF inhibits megakaryocyte formation while stimulating erythroid differentiation, at least partly by repressing Fli-1 mRNA levels, and is uniquely down-regulated in megakaryocytes after MEP formation.\",\n      \"method\": \"Gain- and loss-of-function studies in hematopoietic progenitors, expression profiling, molecular analyses of Fli-1 expression\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — both gain- and loss-of-function with quantitative lineage output measurements and defined molecular mechanism (Fli-1 repression); single lab, multiple methods\",\n      \"pmids\": [\"17715392\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"EKLF is required for cell cycle progression in erythroid progenitors; loss of EKLF leads to reduced E2f2 (and E2f4) expression, G1-to-S phase delay, and failure of terminal differentiation. EKLF directly occupies the E2f2 proximal promoter in vivo and its binding correlates with DNase I sensitivity.\",\n      \"method\": \"ChIP assay, transcriptional profiling, cell cycle analysis, EKLF-null mouse analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-confirmed direct occupancy plus cell cycle phenotype in null mouse; single lab, multiple methods\",\n      \"pmids\": [\"18852285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"EKLF directly regulates E2f2 via novel intronic enhancers containing conserved CACC/GATA/E-box elements that are occupied by EKLF in vivo; genetic depletion of Rb in EKLF(-/-) fetal liver partially rescues the cell cycle defect, establishing epistatic linkage between EKLF, E2f2, and cell cycle entry.\",\n      \"method\": \"ChIP assay, reporter gene assays, genetic epistasis (Rb knockout rescue), cell cycle analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP-confirmed direct binding plus epistasis rescue plus functional reporter assays; replicated in related study (PMID:18852285)\",\n      \"pmids\": [\"19457859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"KLF1 directly activates BCL11A expression in erythroid cells; KLF1 knockdown reduces BCL11A levels and increases gamma-globin/beta-globin expression ratios, establishing that KLF1 controls globin switching by directly activating beta-globin AND indirectly repressing gamma-globin via BCL11A.\",\n      \"method\": \"shRNA knockdown in human and mouse adult erythroid progenitors, gene expression analysis\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function with defined downstream mechanism (BCL11A), replicated in both human and mouse systems\",\n      \"pmids\": [\"20676097\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"KLF1 activates Klf8 gene expression through CACCC sites in both Klf8 promoters; KLF3 competes with KLF1 at these sites to repress Klf8; in Klf3 knockout tissue, KLF1 gains access and activates Klf8 promoters, revealing a direct competitive network between activating (KLF1) and repressing (KLF3) Krüppel-like factors.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), reporter gene assays, Klf3 knockout mouse analysis, promoter competition analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirming in vivo binding plus genetic rescue (KO mouse) plus reporter assays; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"18687676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"EKLF acetylation at lysine 288 is essential for recruitment of CBP to the beta-globin locus, histone H3 modification, chromatin opening (DNase I sensitivity), and beta-globin transcription. EKLF's zinc finger domain associates specifically with the histone H3 amino terminus, and H3.3 (not H3.1) is enriched at the beta-globin promoter in an EKLF-dependent manner.\",\n      \"method\": \"Retroviral EKLF rescue of EKLF-null erythroid line, ChIP, DNase I sensitivity assay, site-directed mutagenesis of K288\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis of acetylation site plus ChIP-based chromatin assays plus functional transcription rescue; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"18710946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BMP4 signaling through the BMP/Smad pathway is necessary and sufficient to induce EKLF (and GATA1) expression during embryoid body differentiation; dominant-negative BMP receptor or inhibitory Smad6 prevents EKLF induction even in serum, establishing the BMP/Smad pathway as upstream of EKLF expression onset.\",\n      \"method\": \"Serum-free embryoid body differentiation, BMP4 treatment, dominant-negative receptor/Smad6 expression in ES cells\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function of pathway components with defined molecular readout (EKLF expression); single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"11807044\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Gata2 and Smad5 cooperate to induce Eklf expression in hematopoietic progenitors prior to erythroid commitment; upon erythroid commitment, regulation switches to Gata1-controlled Eklf transcription.\",\n      \"method\": \"Transgenic reporter assays in differentiating ES cells and fetal liver, phylogenetic footprinting, in vivo ChIP-like binding studies, loss-of-function in embryoid bodies\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo binding studies plus transgenic reporter assays plus loss-of-function; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"18448565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"KLF1 has at least 945 genomic binding sites in E14.5 fetal liver erythroid cells; it occupies promoters of erythroid genes including Hbb-b1 and acts primarily as a transcriptional activator coordinating nearly all aspects of terminal erythroid differentiation including globin production, heme biosynthesis, cell cycle, and red cell membrane/cytoskeleton genes.\",\n      \"method\": \"KLF1 ChIP-seq in primary mouse erythroid cells\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP-seq with direct in vivo occupancy data; large-scale replicated dataset in primary cells\",\n      \"pmids\": [\"20508144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"EKLF directly activates p21(WAF1/CIP1) expression independently of p53 through binding to CACCC motifs in the proximal p21 promoter and a novel conserved intronic region downstream of the TATA box, linking EKLF to cell cycle exit during erythroid maturation.\",\n      \"method\": \"ChIP assay, promoter-reporter assays with mutational analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-confirmed direct binding at two sites plus reporter assays with mutagenesis; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"20368355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"EKLF's minimal transactivation domain (TAD) contains two functional subdomains (TAD1 and TAD2); TAD2 binds the PH domain of the Tfb1/p62 subunit of TFIIH and four domains of CBP/p300. NMR structure of EKLFTAD2/Tfb1PH complex shows TAD2 binds in an extended conformation (distinct from p53TAD2 alpha-helical binding).\",\n      \"method\": \"NMR structure determination, in vitro binding assays, sequence/functional domain analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure plus in vitro binding assays; single lab but structural validation with functional data\",\n      \"pmids\": [\"21670263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"EKLF/KLF1 protein is ubiquitinated in vivo and degraded by the 26S proteasome; EKLF half-life is less than 3 hours in MEL cells and 6–9 hours in fetal liver cells; ubiquitination does not require a specific internal lysine, and PEST sequences within the N-terminus contribute to protein destabilization.\",\n      \"method\": \"Proteasome inhibitor treatment, in vivo ubiquitination assay, pulse-chase protein stability assay, PEST sequence mutagenesis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo ubiquitination demonstrated plus pharmacological and genetic stability analysis; single lab, multiple methods\",\n      \"pmids\": [\"16579989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"A substantial proportion of endogenous EKLF resides in the cytoplasm at steady state in erythroid cells, not solely in the nucleus; EKLF can shuttle out of the nucleus (demonstrated by heterokaryon assay) with rapid nuclear re-entry; nuclear vs. cytoplasmic EKLF shows subtle biochemical and functional differences.\",\n      \"method\": \"Subcellular fractionation, heterokaryon shuttle assay, CRM1 inhibition assay\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct fractionation and heterokaryon assay; single lab, functional consequence of cytoplasmic pool not fully established\",\n      \"pmids\": [\"18329016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"EKLF/KLF1 directly regulates p18 and p27 CDK inhibitor expression to control cell cycle exit; loss of EKLF leads to a block at the orthochromatic erythroblast stage with failure of enucleation; reintroduction of either p18 or p27 rescues both cell cycle and enucleation deficits, establishing that EKLF-controlled cell cycle exit is required for enucleation.\",\n      \"method\": \"Imaging flow cytometry, ex vivo terminal erythroid differentiation culture, epistatic rescue experiments with p18/p27 reintroduction\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistatic rescue (p18/p27 reintroduction) plus direct imaging of enucleation; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"27480112\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"EKLF is required for proper expression of erythrocyte cytoskeletal protein dematin (band 4.9); EKLF occupies conserved CACC motifs in the dematin gene in vivo and activates transcription through these elements; EKLF also regulates alpha-hemoglobin stabilizing protein (AHSP), cytoskeletal proteins, heme synthesis enzymes, and blood group antigens.\",\n      \"method\": \"ChIP assay, promoter reporter assay, expression profiling of EKLF-null fetal liver and EKLF-ER inducible cell lines\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-confirmed direct occupancy plus promoter reporter assays plus two complementary expression profiling systems; single lab\",\n      \"pmids\": [\"16380451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"KLF1 directly binds and activates the Dnase2a promoter in the central macrophage of erythroblastic islands; Dnase2a is severely downregulated in Klf1 KO fetal liver; KLF1 is expressed in erythroblastic island macrophages and exerts a non-cell-autonomous role in erythropoiesis by enabling degradation of extruded erythroid nuclei.\",\n      \"method\": \"ChIP assay (KLF1 occupancy at Dnase2a promoter), KO mouse analysis, expression analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-confirmed direct binding plus genetic KO phenotype; single lab, multiple methods\",\n      \"pmids\": [\"21807894\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"EKLF/KLF1 is expressed in erythroblastic island macrophages (derived from erythro-myeloid progenitors) and plays an extrinsic role in erythroid maturation by regulating genes important for island integrity within macrophage cells, in addition to its intrinsic role in erythroid progenitors.\",\n      \"method\": \"Embryoid body single-progenitor island formation assay, genetic lineage marking, expression analysis in EKLF-expressing macrophages vs. EKLF-null cells\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic lineage demonstration and expression analysis; single lab, island formation assay\",\n      \"pmids\": [\"24866116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"EKLF is recruited to the gamma-globin promoter in primary human erythroid progenitors upon SCFA derivative treatment, functioning as a co-activator for gamma-globin induction; EKLF knockdown prevents SCFA-induced gamma-globin expression; BRG1 is co-recruited to the gamma-globin promoter in an EKLF-dependent manner.\",\n      \"method\": \"ChIP assay (endogenous promoter), siRNA knockdown, gamma-globin reporter assay\",\n      \"journal\": \"European journal of haematology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-confirmed recruitment plus functional KD assay; single lab, two orthogonal methods\",\n      \"pmids\": [\"19220418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"KLF1 directly drives dematin and a broad transcriptome of erythroid genes through a cis-regulatory module co-occupied by KLF1, GATA1, TAL1, and EP300; KLF1 is required for expression of novel lncRNAs and directs apoptotic gene expression during terminal erythroid maturation; KLF1 also drives erythroid-specific promoters of ubiquitous genes.\",\n      \"method\": \"mRNA-seq comparison of Klf1(+/+) vs. Klf1(-/-) erythroid tissue, integration with prior KLF1 ChIP-seq data\",\n      \"journal\": \"Genome research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide mRNA-seq integrated with ChIP-seq occupancy data in primary cells; large-scale dataset with strong genomic support\",\n      \"pmids\": [\"22835905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"c-Myb directly binds the KLF1 promoter and transactivates KLF1 expression; ChIP and luciferase reporter assays demonstrate this direct regulation; KLF1 overexpression can partially rescue the erythroid defect and megakaryocyte bias caused by c-Myb silencing.\",\n      \"method\": \"ChIP assay, luciferase reporter assay, retroviral overexpression rescue experiments\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-confirmed direct binding plus reporter assay plus functional rescue; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"20686118\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"KLF1 stabilizes GATA-1 and TAL1 occupancy at the beta-globin locus and other erythroid genes; KLF1 knockdown reduces GATA-1 and TAL1 chromatin binding without affecting their protein levels, and abolishes histone acetylation and chromatin looping at target loci.\",\n      \"method\": \"KLF1 stable knockdown in K562 cells, ChIP assay for multiple factors and histone marks\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP for multiple factors in KLF1 knockdown system; single lab, two orthogonal methods (KD + ChIP)\",\n      \"pmids\": [\"25528728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In erythroid cells, EKLF forms a novel HDAC complex (NuRSERY) containing HDAC5, GATA1, EKLF, and phospho-ERK (pERK); this complex is absent in megakaryocytic cells; ERK phosphorylation is required for complex formation and nuclear localization of HDAC5, GATA1, and EKLF.\",\n      \"method\": \"Pulldown/co-immunoprecipitation, ERK inhibitor treatment, Western blot analysis\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — co-IP identifying the complex plus pharmacological disruption; single lab, functional consequence partially inferred\",\n      \"pmids\": [\"24594363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The British HPFH mutation (-198 T>C in the gamma-globin promoter) creates a de novo KLF1 binding site, and KLF1 directly binds this site to activate fetal globin expression; CRISPR introduction of -198 C into HUDEP-2 cells substantially elevates HbF.\",\n      \"method\": \"CRISPR/Cas9 genome editing, in vitro and in vivo binding assays, reporter assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR functional edit plus direct binding assays; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"28659276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"KLF1 directly activates ZBTB7A/LRF expression in erythroid cells by binding to the ZBTB7A proximal promoter; KLF1 also drives expression of a novel erythroid-specific ZBTB7A transcript, establishing ZBTB7A as a KLF1 target gene involved in gamma-globin repression.\",\n      \"method\": \"ChIP assay, promoter reporter assay, expression analysis\",\n      \"journal\": \"Blood advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-confirmed direct binding plus reporter assay; single lab, two orthogonal methods\",\n      \"pmids\": [\"29296711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"EKLF/KLF1 acts as a pioneer transcription factor and regulates transcription through selective RNA polymerase II pause-release; in the Nan/+ mouse (EKLF-E339D variant), Nan-EKLF limits normal EKLF binding at a subset of sites and ectopically binds largely at enhancers, activating neomorphic target genes through pioneering and Pol II pause-release mechanisms.\",\n      \"method\": \"ChIP-seq in wild-type and Nan/+ mouse embryonic erythroid cells, GRO-seq/RNA Pol II occupancy analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP-seq with mechanistic comparison of normal vs. variant EKLF binding; single lab, rigorous genomic approach\",\n      \"pmids\": [\"36543143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Correction of globin chain imbalance in EKLF-null embryos by gamma-globin transgene does not correct hemolysis or extend survival, establishing that nonglobin EKLF target genes are essential for definitive red blood cell function.\",\n      \"method\": \"Genetic complementation (gamma-globin transgene on EKLF-null background), hematological analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistatic rescue experiment showing that globin correction is insufficient; replicated in independent studies (PMID:9242564, PMID:16728274)\",\n      \"pmids\": [\"10688844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"EKLF directly activates the Klf3 gene, which then represses a subset of KLF1 target genes; KLF3 knockout mice exhibit impaired erythroid maturation, and KLF3 acts primarily as a feedback repressor countering EKLF activity at selected erythroid target genes.\",\n      \"method\": \"Klf3 knockout mouse analysis, microarray expression profiling, promoter analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO plus expression profiling; single lab, two complementary methods\",\n      \"pmids\": [\"22711990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"EKLF directly activates PIT1/SLC20A1 expression during RBC maturation by binding to the PIT1 promoter in vivo; shRNA depletion of either PIT1 or EKLF impairs erythroid maturation, and re-expression of PIT1 in EKLF-depleted cells partially restores maturation.\",\n      \"method\": \"ChIP assay (EKLF at PIT1 promoter), shRNA knockdown, epistatic rescue by PIT1 re-expression\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus shRNA KD plus epistatic rescue; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"23190530\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"KLF1 directly activates KLF2 expression and binds Myc promoters; KLF1 and KLF2 synergistically regulate Myc expression in embryonic erythroid cells; Myc ablation in embryonic proerythroblasts recapitulates KLF1/KLF2 double-KO anemia phenotype.\",\n      \"method\": \"Expression profiling, ChIP assay, genetic epistasis (Myc conditional KO in erythroid cells)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus genetic epistasis; single lab, two methods\",\n      \"pmids\": [\"22566683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"EKLF/KLF1 expression defines a unique macrophage subset (erythroblastic island macrophages) during fetal liver erythropoiesis; single-cell sequencing identifies EKLF-dependent gene clusters and novel cell surface biomarkers specific to this macrophage population, which appears transiently during embryogenesis.\",\n      \"method\": \"Single-cell RNA-seq, global sequencing, genetic EKLF marking and KO analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-cell sequencing plus genetic KO and marking; single lab, multiple genomic methods\",\n      \"pmids\": [\"33570494\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KLF1/EKLF is a zinc-finger transcription factor that functions as a master erythroid regulator: it binds CACCC/CACC elements via its three zinc fingers to directly activate a broad suite of erythroid genes (beta-globin, BCL11A, ZBTB7A/LRF, dematin, E2f2, p21, p18/p27, PIT1, and others), requires a SWI/SNF (E-RC1/BRG1) chromatin remodeling complex for chromatin opening at target loci, and is modulated by post-translational modifications including acetylation by CBP/p300 (at K288, toggling coactivator vs. corepressor interactions with Sin3A/HDAC1) and sumoylation by PIAS1 (enabling NuRD/Mi-2β repressor interactions to inhibit megakaryopoiesis); its transactivation domain interacts with TFIIH (Tfb1/p62) and CBP/p300 in a structurally defined manner; KLF1 controls hemoglobin switching both by directly activating beta-globin and by activating the gamma-globin repressors BCL11A and ZBTB7A; it regulates cell cycle progression (via E2f2, p21, p18/p27) to enable terminal erythroid differentiation and enucleation; it is expressed in and regulates erythroblastic island macrophages in a non-cell-autonomous role; and it antagonizes the megakaryocyte transcription factor FLI-1 to enforce erythroid over megakaryocyte lineage commitment.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"KLF1 (EKLF) is the master transcriptional regulator of definitive erythropoiesis, coordinating nearly all aspects of terminal red cell maturation including globin production, heme biosynthesis, cell cycle exit, and membrane/cytoskeletal gene expression through genome-wide occupancy of CACCC/CACC elements [#0, #21, #31]. It binds the beta-globin CACCC element via its zinc fingers, where thalassemia point mutations that weaken binding abolish transactivation, and it directly activates the locus control region site 5'HS3 [#1, #9]. KLF1 is embedded in the erythroid regulatory hierarchy downstream of GATA-1, which directly activates the EKLF promoter through a GATA-E box-GATA composite element, while KLF1 reciprocally interacts and synergizes with GATA-1 and stabilizes GATA-1/TAL1 occupancy, histone acetylation, and chromatin looping at target loci [#2, #3, #8, #20, #33]. Productive activation requires recruitment of a SWI/SNF-related chromatin remodeling complex (E-RC1/BRG1) to open chromatin at target promoters, and KLF1 functions as a pioneer factor controlling RNA polymerase II pause-release [#5, #37]. KLF1 is a master switch for hemoglobin switching: it directly activates adult beta-globin while simultaneously activating the gamma-globin repressors BCL11A and ZBTB7A/LRF, and a British HPFH mutation creates a de novo KLF1 site that activates fetal globin [#16, #35, #36]. It drives terminal differentiation by directly activating cell-cycle regulators E2f2, p21, and the CDK inhibitors p18/p27, the latter being required for cell cycle exit and enucleation [#14, #15, #22, #26]. KLF1 also enforces erythroid versus megakaryocyte lineage choice through mutual antagonism with FLI-1 and by repressing Fli-1, and it acts non-cell-autonomously in erythroblastic island macrophages by directly activating Dnase2a to enable degradation of extruded nuclei [#12, #13, #28, #42]. Its activity is tuned by post-translational modifications: CBP/p300 acetylation at K288 toggles coactivator versus Sin3A/HDAC1 corepressor interactions and is required for chromatin opening, while PIAS1-mediated sumoylation enables NuRD/Mi-2beta-dependent repression [#10, #11, #18].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing how EKLF reaches its erythroid target and where it sits in the regulatory hierarchy was first addressed by defining its DNA element and its upstream activator.\",\n      \"evidence\": \"In vitro/in vivo binding and transactivation at the beta-globin CACCC element, and promoter dissection of the EKLF gene driven by GATA-1\",\n      \"pmids\": [\"8288615\", \"8195185\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address chromatin context or cofactor requirements for transactivation\", \"Genome-wide target spectrum unknown at this stage\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Whether EKLF is functionally essential and how it cooperates with other erythroid factors was resolved by knockout and physical interaction studies.\",\n      \"evidence\": \"EKLF knockout mice (fatal anemia, beta-globin deficit) and Co-IP/synergy assays with GATA-1\",\n      \"pmids\": [\"7753195\", \"7753194\", \"7739528\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether anemia stems from globin loss alone or other targets was unresolved\", \"Mechanism of GATA-1/EKLF synergy on chromatin not defined\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Dissection of the transactivation domain into stimulatory and inhibitory subdomains revealed that EKLF activity is conformationally gated and cofactor-dependent.\",\n      \"evidence\": \"Deletion/mutagenesis and DNA-binding competition assays of the proline-rich TAD\",\n      \"pmids\": [\"8918466\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the positive-acting cellular factor not defined here\", \"Single-lab functional mapping without structural data\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"How EKLF mechanically activates transcription on chromatin and how it is post-translationally controlled was established through chromatin remodeling, acetylation, and phosphorylation studies.\",\n      \"evidence\": \"In vitro chromatin-template reconstitution with purified E-RC1/SWI/SNF complex, CBP/p300/P-CAF acetylation assays, CKII phosphorylation and mutagenesis, and transgenic 5'HS3 specificity assays\",\n      \"pmids\": [\"9778250\", \"9707565\", \"9722526\", \"9744863\", \"9603943\", \"10688820\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Acetylated residue and its functional consequence not yet pinpointed\", \"How PTMs integrate to switch activator/repressor states unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Whether EKLF's essential role is reducible to globin regulation was tested by genetic complementation, establishing that non-globin targets are required for red cell function.\",\n      \"evidence\": \"Gamma-globin transgene complementation on EKLF-null background with hematological analysis\",\n      \"pmids\": [\"10688844\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The specific essential non-globin targets were not identified here\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"The basis of erythroid versus megakaryocyte lineage decision was clarified by demonstrating mutual transcriptional antagonism between EKLF and FLI-1.\",\n      \"evidence\": \"Co-IP, Gal4-domain mapping, and reciprocal reporter repression assays\",\n      \"pmids\": [\"12556498\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo lineage consequences of the antagonism not measured in this study\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"How EKLF can both activate and repress was resolved by linking its acetylation status to a choice between coactivators and Sin3A/HDAC1 corepressors.\",\n      \"evidence\": \"Co-IP, point mutagenesis of a key lysine, and stage-specific repression assays\",\n      \"pmids\": [\"15542849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How stage-specific signals dictate acetylation state in vivo not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"EKLF protein turnover was characterized, showing it is a short-lived, proteasome-degraded factor.\",\n      \"evidence\": \"Proteasome inhibition, in vivo ubiquitination, pulse-chase stability, and PEST mutagenesis\",\n      \"pmids\": [\"16579989\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"The responsible E3 ligase was not identified\", \"Physiological signals controlling turnover unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"EKLF's roles in cell cycle progression, in transcriptional networks with other KLFs, in repression via sumoylation, and in upstream induction were defined through ChIP, genetic, and PTM studies.\",\n      \"evidence\": \"ChIP at E2f2 promoter with cell-cycle phenotyping, KLF3 promoter competition with Klf3-KO analysis, PIAS1-mediated sumoylation/NuRD co-IP, K288 acetylation ChIP rescue, Gata2/Smad5-driven Eklf induction, and demonstration of a cytoplasmic EKLF pool\",\n      \"pmids\": [\"18852285\", \"18687676\", \"17938210\", \"18710946\", \"18448565\", \"18329016\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of the cytoplasmic EKLF pool not established\", \"How acetylation/sumoylation are coordinated in vivo unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Direct genetic linkage between EKLF, E2f2, and cell cycle entry was established, and EKLF was shown to act as a gamma-globin co-activator under SCFA induction.\",\n      \"evidence\": \"ChIP at E2f2 intronic enhancers with Rb-knockout epistasis rescue, and EKLF/BRG1 recruitment at the gamma-globin promoter\",\n      \"pmids\": [\"19457859\", \"19220418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Context-dependence of EKLF acting at gamma-globin versus repressing it via BCL11A not reconciled here\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Genome-wide occupancy and the globin-switching mechanism were defined, establishing KLF1 as a global activator and a dual controller of hemoglobin switching.\",\n      \"evidence\": \"KLF1 ChIP-seq in primary fetal liver erythroid cells, BCL11A knockdown studies, p21 ChIP/reporter assays, dematin/cytoskeletal target profiling, and c-Myb-driven KLF1 activation\",\n      \"pmids\": [\"20508144\", \"20676097\", \"20368355\", \"16380451\", \"20686118\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct functional dissection of most of the >945 binding sites not performed\", \"Hierarchy among the many activated programs not ranked\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"The structural basis of TAD-cofactor contacts, KLF1's role in macrophage Dnase2a regulation, and synergy with KLF2 at Myc were defined.\",\n      \"evidence\": \"NMR structure of EKLFTAD2/Tfb1PH with CBP/p300 binding, ChIP at the macrophage Dnase2a promoter with KO analysis, and KLF1/KLF2 ChIP/Myc epistasis\",\n      \"pmids\": [\"21670263\", \"21807894\", \"22566683\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural model limited to TAD2/Tfb1PH; full coactivator complex geometry unknown\", \"Non-cell-autonomous macrophage contribution not quantitatively separated from intrinsic role\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Integrated transcriptomic and genetic studies extended KLF1's regulatory reach to a cis-regulatory module shared with GATA1/TAL1/EP300, to feedback repressor KLF3, and to PIT1.\",\n      \"evidence\": \"mRNA-seq of Klf1+/+ vs Klf1-/- integrated with ChIP-seq, Klf3-KO profiling, and PIT1 ChIP/shRNA/rescue\",\n      \"pmids\": [\"22835905\", \"22711990\", \"23190530\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional roles of KLF1-dependent lncRNAs not characterized\", \"How activating and repressive KLF subnetworks balance quantitatively unresolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"KLF1's mechanism of stabilizing partner-factor occupancy, its assembly into an HDAC (NuRSERY) complex, and its macrophage-extrinsic role were further detailed.\",\n      \"evidence\": \"ChIP after KLF1 knockdown showing reduced GATA-1/TAL1 binding, NuRSERY complex Co-IP with ERK-dependence, and embryoid-body island formation with EKLF macrophage marking\",\n      \"pmids\": [\"25528728\", \"24594363\", \"24866116\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"NuRSERY complex functional output partially inferred from pharmacology\", \"Mechanism by which KLF1 stabilizes partner occupancy not structurally defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The causal link between KLF1-controlled cell cycle exit and enucleation was established by epistatic rescue.\",\n      \"evidence\": \"Imaging flow cytometry of terminal differentiation with p18/p27 reintroduction rescue in EKLF-deficient cells\",\n      \"pmids\": [\"27480112\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ChIP occupancy at p18/p27 loci not the focus of this study\", \"Mechanical link between cell cycle exit and nuclear extrusion machinery not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Direct activation of the gamma-globin repressor ZBTB7A and the gain-of-binding HPFH mechanism cemented KLF1's central role in fetal-to-adult globin switching.\",\n      \"evidence\": \"ZBTB7A promoter ChIP/reporter assays and CRISPR introduction of the -198 T>C gamma-globin promoter variant in HUDEP-2 cells\",\n      \"pmids\": [\"29296711\", \"28659276\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Quantitative contribution of ZBTB7A vs BCL11A to switching not resolved here\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Single-cell profiling defined KLF1-expressing erythroblastic island macrophages as a discrete transient population with KLF1-dependent gene clusters.\",\n      \"evidence\": \"Single-cell RNA-seq with genetic EKLF marking and KO analysis in fetal liver\",\n      \"pmids\": [\"33570494\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional necessity of individual KLF1-dependent macrophage genes for island integrity not dissected\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"KLF1 was defined as a pioneer factor acting through Pol II pause-release, and the Nan/+ variant was shown to drive neomorphic binding and target activation.\",\n      \"evidence\": \"ChIP-seq and GRO-seq/Pol II occupancy in wild-type and Nan/+ (E339D) erythroid cells\",\n      \"pmids\": [\"36543143\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generalizability of pioneering across all KLF1 sites not established\", \"Molecular basis of Nan-EKLF enhancer redirection not fully defined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many KLF1 post-translational modifications, partner-stabilizing functions, and pioneering activity are integrated in real time to switch between activator and repressor states across erythroid maturation stages remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking acetylation, sumoylation, phosphorylation, and turnover to stage-specific output\", \"Quantitative hierarchy among hundreds of direct targets undefined\", \"E3 ligase and signaling control of KLF1 abundance unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 16, 21, 31, 37]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 9, 21, 35]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": []}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [21, 25]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 21, 31]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 13, 26, 38]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [14, 15, 22, 26]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [5, 18, 37]}\n    ],\n    \"complexes\": [\"E-RC1 (SWI/SNF/BRG1)\", \"NuRSERY (HDAC5/GATA1/EKLF/pERK)\", \"NuRD (Mi-2beta)\"],\n    \"partners\": [\"GATA1\", \"BRG1\", \"CBP\", \"EP300\", \"FLI1\", \"PIAS1\", \"TAL1\", \"Sin3A\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}